6640--VISN 8 Electrophoresis Testing

The Department of Veterans Affairs, through Network Contracting Office 8 in Tampa, Florida, has awarded a five-year fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Sebia, Inc. for automated capillary protein electrophoresis testing services across VISN 8 facilities, with a total estimated value of $4,091,294 and annual funding of $818,258.80. The contract period runs from April 1, 2026 through March 31, 2031, and includes the provision of testing services for serum protein, urine protein, hemoglobin, immunotyping, carbohydrate-deficient transferrin, urine immunofixation, and CSF oligoclonal band analysis using Sebia’s proprietary Octa3 analyzer platform. The award is a sole-source procurement justified under FAR 12.102(b) due to the proprietary nature of Sebia’s instrumentation and software, which are essential for maintaining historical patient data continuity, ensuring diagnostic accuracy, and achieving interoperability with existing laboratory systems across multiple VA medical centers in Florida, including Orlando, San Juan, Miami, West Palm Beach, and Tampa. No other vendor can meet the agency’s clinical and technical requirements, particularly for CDT and CSF testing, and the system’s integration capabilities. Sebia, Inc. is identified as a large business with no socioeconomic certifications, and the procurement explicitly excludes competition due to technical exclusivity and regulatory clearance requirements. The contract involves delivery of reagents, consumables, maintenance, and proprietary software for longitudinal data trending, with inspection and acceptance occurring at the point of service within VA laboratories. Packaging, marking, invoicing methods, payment office details, accounting codes, and specific contract administration personnel are not specified in the available documentation. While the acquisition was conducted under Simplified Acquisition Procedures for Commercial Items and required a sole source declaration and market research validation, no evaluation factors, pricing line items, or formal clause listings were disclosed. The contracting officer, Todd Pappas, serves as the primary point of contact, and all performance is tied to destination-based delivery at VA facilities within VISN 8. The procurement does not invoke the Buy American Act, as Sebia is a U.S.-based manufacturer, and no options, alternates, or modifications are indicated beyond the five-year structured term.